{
    "nctId": "NCT02679378",
    "briefTitle": "Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy",
    "officialTitle": "Clinical Study of the ClearSight\u2122 System to Evaluate the Ability to Distinguish Malignant From Non-malignant Breast Tissue by Comparing MR Measurements of Freshly Excised Breast Tissue to Histopathology",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 220,
    "primaryOutcomeMeasure": "Malignant and non-malignant breast tissues will be assessed by ClearSight\u2122 to detect malignant tissue less than or equal to 1 mm of margins of excised breast specimen in breast conserving surgery using histopathological assessment as reference",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women histologically diagnosed with carcinoma of the breast, scheduled for primary lumpectomy (partial mastectomy) procedure.\n2. Age \u226518.\n3. Signed ICF\n\nExclusion Criteria:\n\n1. Prior surgical procedure in the same breast within 12 months prior to the surgery date.\n2. Recurrent breast cancer surgery.\n3. Neoadjuvant chemotherapy.\n4. Previous radiation therapy to the operated breast.\n5. Pregnant / breast feeding.\n6. Participating in any other study that might affect results.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}